药物对比
Galcanezumab vs Fremanezumab
Galcanezumab（Emgality）和 Fremanezumab（Ajovy）均通过阻断 CGRP 预防偏头痛。两者的给药频率不同，但疗效和安全性相似。
此页面暂无可用的对比维度。
临床背景
Patients with chronic or episodic migraines considering CGRP inhibitor therapy may compare Galcanezumab and Fremanezumab for differences in injection frequency.
结论
Both drugs are comparably effective CGRP inhibitors; selection depends on dosing preference and individual factors.
全部药物对比